Bone Cancer Clinical Trial
Official title:
Genomic Analysis of Pediatric Bone Tumors (Other Title: Pediatric Bone Tumor Biology Study)
To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03905174 -
Massive Implants the Next Generation
|
N/A | |
Completed |
NCT00160719 -
HLA Sensitization Following Major Cortical Allograft Bone Procedures
|
Phase 4 | |
Completed |
NCT04974008 -
Osteosarcoma Maintenance Therapy With OST31-164
|
Phase 2 | |
Not yet recruiting |
NCT06070259 -
Insights Into Participating in Studies for Bone Cancer
|
||
Completed |
NCT01553539 -
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
|
Phase 2 | |
Recruiting |
NCT03160274 -
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
|
||
Active, not recruiting |
NCT02880319 -
Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone
|
Phase 2 | |
Completed |
NCT01135849 -
B-Receptor Signaling in Cardiomyopathy
|
N/A | |
Terminated |
NCT00960063 -
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
|
Phase 1 | |
Terminated |
NCT02443103 -
Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis
|
N/A | |
Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
Terminated |
NCT03525392 -
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
|
Phase 1 | |
Terminated |
NCT01541358 -
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
|
N/A | |
Terminated |
NCT01313884 -
Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
|
Phase 2 | |
Completed |
NCT01091883 -
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
|
N/A | |
Terminated |
NCT00127387 -
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT03106675 -
MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases
|
N/A | |
Recruiting |
NCT05830084 -
Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma
|
Phase 1 | |
Completed |
NCT01085565 -
Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System
|
Phase 2 | |
Recruiting |
NCT04307914 -
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases
|
N/A |